Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04107727
Title Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors PETHEMA Foundation
Indications

acute myeloid leukemia

Therapies

Cytarabine

Cytarabine + Idarubicin

Cytarabine + Idarubicin + Quizartinib

Quizartinib

Cytarabine + Quizartinib

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST